Figures computed from official regulatory filings — .
Statistical track record
FreeWin rates and median returns are available with a free account (5 insiders/month).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Details | |
|---|---|---|---|---|
Avalo Therapeutics, Inc.Listing on record | Sell | $487.5K | SEC | |
Avalo Therapeutics, Inc.Listing on record | Sell | $1.7M | SEC | |
TENAX THERAPEUTICS, INC.Listing on record | AwardD (derivative) | — | SEC | |
TENAX THERAPEUTICS, INC.Listing on record | OtherD (derivative) | — | SEC | |
TENAX THERAPEUTICS, INC.Listing on record | OtherD (derivative) | — | SEC | |
TENAX THERAPEUTICS, INC.Listing on record | AwardD (derivative) | — | SEC | |
TENAX THERAPEUTICS, INC.Listing on record | OtherD (derivative) | — | SEC | |
TENAX THERAPEUTICS, INC.Listing on record | OtherD (derivative) | — | SEC | |
TENAX THERAPEUTICS, INC.Listing on record | AwardD (derivative) | — | SEC | |
TENAX THERAPEUTICS, INC.Listing on record | AwardD (derivative) | — | SEC | |
TENAX THERAPEUTICS, INC.Listing on record | OtherD (derivative) | — | SEC | |
TENAX THERAPEUTICS, INC.Listing on record | AwardD (derivative) | — | SEC | |
TENAX THERAPEUTICS, INC.Listing on record | AwardD (derivative) | — | SEC | |
TENAX THERAPEUTICS, INC.Listing on record | AwardD (derivative) | — | SEC | |
Avalo Therapeutics, Inc.Listing on record | Buy | $80K | SEC | |
Avalo Therapeutics, Inc.Listing on record | Buy | $31.6K | SEC | |
Avalo Therapeutics, Inc.Listing on record | Buy | $486.2K | SEC | |
Avalo Therapeutics, Inc.Listing on record | Buy | $143.4K | SEC | |
Avalo Therapeutics, Inc.Listing on record | Buy | $15.4K | SEC | |
AYTU BIOPHARMA, INCListing on record | Other | — | SEC | |
AYTU BIOPHARMA, INCListing on record | Other | — | SEC | |
AYTU BIOPHARMA, INCListing on record | Other | — | SEC | |
AYTU BIOPHARMA, INCListing on record | Other | — | SEC | |
Avalo Therapeutics, Inc.Listing on record | Other | — | SEC | |
Avalo Therapeutics, Inc.Listing on record | OtherD (derivative) | — | SEC |